NDC 42638-7666 Mycratine Migraine Relief

Product Information

Product Packages

NDC 42638-7666-3

Package Description: 1 BOTTLE in 1 BOX > 60 mL in 1 BOTTLE (42638-7666-2)

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Product Details

Mycratine Migraine Relief is product labeled by Nico Worldwide, Inc.. The product's dosage form is and is administered via form.


What are Mycratine Migraine Relief Active Ingredients?

The following is the list of active ingredients in this product. An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

  • NICOTINE (UNII: 6M3C89ZY6R)
  • NICOTINE (UNII: 6M3C89ZY6R) (Active Moiety)
  • TYROSINE (UNII: 42HK56048U)
  • TYROSINE (UNII: 42HK56048U) (Active Moiety)
  • PHENYLALANINE (UNII: 47E5O17Y3R)
  • PHENYLALANINE (UNII: 47E5O17Y3R) (Active Moiety)
  • TRYPTOPHAN (UNII: 8DUH1N11BX)
  • TRYPTOPHAN (UNII: 8DUH1N11BX) (Active Moiety)
  • CAFFEINE (UNII: 3G6A5W338E)
  • CAFFEINE (UNII: 3G6A5W338E) (Active Moiety)


Inactive Ingredient(s)

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product.

  • WATER (UNII: 059QF0KO0R)
  • SUCRALOSE (UNII: 96K6UQ3ZD4)
  • SODIUM CITRATE (UNII: 1Q73Q2JULR)
  • SODIUM BENZOATE (UNII: OJ245FE5EU)


* Please review the disclaimer below.

Mycratine Migraine Relief Labeling and Warnings

FDA filings in the form of structured product labels are documents that include all published material associated whith this product. Product label information includes data like indications and usage generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Table of Contents



Package Label.Principal Display Panel



Mycratine Label Description


Otc - Active Ingredient



Ingredients

  • Nicotinum (6x)
  • In a base of: Caffeine, L-Tyrosine, L-Tryptophan, L-Phenylalanine


Otc - Purpose



Mycratine Migraine Relief

Advanced Relief Formula

Liquid Shot


Otc - Keep Out Of Reach Of Children



Keep out of reach of children.


Indications & Usage



Indications:

For the relief/treatment of migraines and headaches

Intended for adult use only


Warnings



Warning:

Do not use if pregnant or breast-feeding or have pheylketonuria.

Consult your doctor or health care professional before use if you are taking prescription medication for depression such as MAO inhibitors or have asthma, high blood pressure, stomach ulcers, diabetes, or hyperthyroidism.

This product contains nicotine, a chemical known to the state of California to cause birth defects or other reproductive harm.

Caution:

  • For any suspected or known illness or dysfunction, always consult your physician or medical adviser first.
  • Do not use if seal is broken.
  • Discard any unused portion after 24 hours.
  • Store in a cool, dry place (50-90 F). Avoid excessive heat and extreme cold.

Dosage & Administration



Directions:

  • Shake well.
  • Drink one bottle at first indication of migraine. Wait 5 to 15 minutes.  Migraine symptoms should decrease significantly and allow you to return to your normal activities.
  • In extreme migraine cases it may be necessary to take a second bottle 15 minutes after the first bottle. 
  • Recommended dosage not to exceed four bottles a day.
  • Refrigerate after opening.

Inactive Ingredient



Inactive Ingredients:

purified water, gum acacia, lemon oil, brominated vegetable oil, ester gum, citric acid, sodium benzoate, sucralose.


Other Safety Information



Questions or comments: [email protected]

Homeopathic Complex Formula

Patent Pending

NDC 42638-7666-2


* Please review the disclaimer below.